MK-1293 Insulin Glargine is a Safe and Effective Treatment Option for Type 2 Diabetes
Injection site reactions reported in 1.9% of participants in the MK-1293 group, including pain and discomfort.
A hip fracture risk tool for patients with type 2 diabetes performed well in predicting incident hip fractures using readily available variables.
Postpartum women with an elevated BMI score and a history of hypertensive disorders during pregnancy have an increased risk of developing type 2 diabetes.
Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only.